Abstract
Some cinobufagin oxime ether derivatives as potential Na+/K+-ATPase inhibitors were synthesized by following the side chain of istaroxime. These compounds inhibit Na+/K+-ATPase in a dose-dependent manner. Compound 3c with an oxyethylamine side chain that is the same as that of istaroxime showed the most potent inhibition, which was stronger than compound 3a with only hydroxyoxime moiety at C-3 and compound 3b with a methylated hydroxyoxime moiety. Molecular docking was used to explore the binding modes of the target compounds with Na+/K+-ATPase, which suggested that the longer ethyl amine group at C-3 oxime moiety of compound 3c could make stronger interaction with Na+/K+-ATPase via intermolecular charge-charge and H-bond interaction as compared with other derivatives.
Similar content being viewed by others
References
Skou J. C., Angew. Chem. Int. Ed., 1998, 37, 2320
Kaplan J. H., Annu. Rev. Biochem., 2002, 71, 511
Laursen M., Gregersen J. L., Yatime L., Nissen P., Fedosova N. U., P. Natl. Acad. Sci. USA, 2015, 112, 1755
Bavishi C., Khan A. R., Ather S., Int. J. Cardiol., 2015, 188, 99
Li Z., Xie Z., Pfluügers Arch, 2009, 457, 635
Prassas I., Diamandis E. P., Nat. Rev. Drug Discov., 2008, 7, 926
Tian H. Y., Wang L., Zhang X. Q., Zhang D. M., Wang Y., Jiang R. W., Ye W. C., Steroids, 2010, 75, 884
Tian H. Y., Wang L., Zhang X. Q., Wang Y., Zhang D. M., Jiang R. W., Liu Z., Liu J. S., Li Y. L., Ye W. C., Chem. Eur. J., 2010, 16, 10989
Tian H. Y., Luo S. L., Liu J. S., Wang L., Wang Y., Zhang D. M., Zhang X. Q., Jiang R. W., Ye W. C., J. Nat. Prod., 2013, 76, 1842
Li B. J., Tian H. Y., Zhang D. M., Lei Y. H., Wang L., Jiang R. W., Ye W. C., Fitoterapia, 2015, 105, 7
Tian H. Y., Zhang P. W., Liu J. S., Zhang D. M., Zhang X. Q., Jiang R. W., Ye W. C., Chin. Chem. Lett., 2014, 25, 1104
Cheng W., Tan Y. F., Tian H. Y., Gong X. W., Chen K. L., Jiang R. W., Nat. Prod. Res., 2014, 28, 901
Zhang R. R., Tian H. Y., Tan Y. F., Chung T. Y., Sun X. H., Xia X., Ye W. C., Middleton D. A., Fedosova N., Esmann M., Tzen J. T. C., Jiang R. W., Org. Biomol. Chem., 2014, 12, 8919
Tian H. Y., Yuan X. F., Jin L., Li J., Luo C., Ye W. C., Jiang R. W., Chem. Biol. Interact., 2014, 207, 16
Zhang P. W., Tang H. J., Tian H. Y., Zhang R. R., Jiang R. W., Chin. J. Struct. Chem., 2014, 33, 1123
Gobbini M., Armaroli S., Banfi L., Benicchio A., Carzana G., Fe-drizzi G., Ferrari P., Giacalone G., Giubileo M., Marazzi G., Miche-letti R., Moro B., Pozzi M., Scotti P. E., Torri M., Cerri A., J. Med. Chem., 2008, 51, 4601
Aditya S., Rattan A., J. Pharmacol. Pharmacother., 2012, 3, 353
Meng Q., Yau L. F., Lu J. G., Wu Z. Z., Zhang B. X., Wang J. R., Jiang Z. H., J. Ethnopharmacol., 2016, 187, 74
Hirai Y., Morishita S., Ito C., Sakanashi M., Nihon Yakurigaku Zasshi, 1992, 100, 127
Wang Z. J., Sun L., Heinbockel T., PLoS One, 2014, 9, e113272
Zhang G., Wang C., Sun M., Li J., Wang B., Jin C., Hua P., Song G., Zhang Y., Nguyen L. L., Cui R., Liu R., Wang L., Zhang X., Onco-target, 2016, 7, 28935
Li P., Song Q., Liu T., Wu Z., Chu X., Zhang X., Zhang Y., Gao Y., Zhang J., Chu L., Scientific World Journal, 2014, 2014, 496705
Hao S., Bao Y. M., An L. J., Cheng W., Zhao R. G., Bi J., Wang H. S., Sun C. S., Liu J. W., Jiang B., Toxicol. in Vitro, 2011, 25, 1644
Zhang Z., Li Z., Tian J., Jiang W., Wang Y., Zhang X., Li Z., You Q. D., Shapiro J. I., Si S., Xie Z., Mol. Pharmacol., 2010, 77, 961
Xie Z., Wang Y., Liu G., Zolotarjova N., Periyasamy S. M., Askari A., Arch. Biochem. Biophys., 1996, 330, 153
Brooks B. R., Bruccoleri R. E., Olafson B. D., States D. J., Swami-nathan S., Karplus M., J. Comp. Chem., 1983, 4, 187
Dixon S. L., Jr. Merz K. M., J. Med. Chem., 2001, 44, 3795
He X. J., Tang J. S., Qiao A. M., Wang G. H., Jiang M. M., Liu R. H., Yao X. S., Steroids, 2006, 71, 392
Author information
Authors and Affiliations
Corresponding authors
Additional information
Supported by the National Natural Science Foundation of China(No.81573315), the Guangdong Natural Science Fund, China(No.2015A030313313) and the Guangzhou Industry-University Collaborative Innovation Major Projects, China(No. 201508030016).
Rights and permissions
About this article
Cite this article
Liang, G., Chung, T., Guo, J. et al. Novel cinobufagin oxime ether derivatives as potential Na+/K+-ATPase inhibitors: Synthesis, biological screening and molecular docking. Chem. Res. Chin. Univ. 33, 378–383 (2017). https://doi.org/10.1007/s40242-017-6487-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40242-017-6487-1